Zdrowie i gospodarka · 27/01/1999
FDA Announces Pilot Program for Gamma Irradiated Blood and Blood Components
The FDA is launching a pilot program to allow licensed blood product manufacturers to market irradiated blood components across state lines, and is seeking public comment on a draft guidance document outlining the program's criteria and procedures.